Automated Visual Field Analyzer Market Trends
The rising prevalence of glaucoma and other eye disorders is a significant driver for the market. Glaucoma, often referred to as the silent thief of sight, is one of the leading causes of irreversible blindness globally. According to Opthalmology Journal, in 2013, the number of people (aged 40-80 years) with glaucoma worldwide was estimated to be 64.3 million, increasing to 76 million in 2020 and 111.8 million in 2040.
- This condition, characterized by progressive optic nerve damage and vision loss, necessitates early and accurate diagnosis to prevent permanent visual impairment. Automated visual field analyzers play a critical role in detecting visual field defects caused by glaucoma at early stages, making them indispensable tools in ophthalmology.
- Moreover, the increasing incidence of other eye disorders such as age-related macular degeneration (AMD), and cataracts further fuels demand. These conditions require regular monitoring of visual field changes to guide treatment decisions effectively. For instance, according to International Agency for the Prevention of Blindness, approximately 5% of blindness globally is due to AMD. It is estimated that globally 196 million people have AMD in 2020, increasing to 288 million in 2040. The rise in these disorders is driven by factors such as aging populations, lifestyle changes, and the increasing burden of chronic diseases like diabetes.